Jorveza (budesonide)

pCPA File Number: 21316

Negotiation Status:

Concluded without agreement

Indication(s):

Eosinophilic Esophagitis (Induction)

Sponsor/Manufacturer:

AVIR Pharma Inc.

CDA-AMC Project Number:

SR0634-000

pCPA Engagement Letter Issued:

2021-10-22

Negotiation Process Concluded:

2022-07-20